Michael Millar
About Michael Millar
Michael Millar is a Senior Scientist with extensive experience in manufacturing sciences, currently working at Adaptimmune in Philadelphia. He has previously held positions at ImClone Systems and Eli Lilly and Company, where he contributed to cell culture manufacturing and other scientific roles.
Work at Adaptimmune
Michael Millar has been employed at Adaptimmune as a Senior Scientist since 2018. In this role, he contributes to the company's research and development efforts, focusing on innovative therapies in the field of immunotherapy. His work involves applying his expertise in cell culture and manufacturing sciences to advance Adaptimmune's mission of developing T-cell therapies for cancer treatment.
Previous Experience at Eli Lilly and Company
Michael Millar has held multiple positions at Eli Lilly and Company. He began as a Senior Associate in Manufacturing Sciences at the Branchburg, NJ facility from 2010 to 2015. Following this role, he transitioned to Principal Associate in Manufacturing Sciences, where he has worked since 2015. His extensive experience at Eli Lilly has equipped him with a deep understanding of manufacturing processes and quality assurance in pharmaceutical production.
Experience at ImClone Systems
Before joining Eli Lilly, Michael Millar worked at ImClone Systems, a subsidiary of Eli Lilly, as a Senior Operator in Cell Culture Manufacturing from 2007 to 2010. His responsibilities included overseeing cell culture processes, which are critical for the production of biopharmaceuticals. This experience provided him with foundational skills in biomanufacturing and quality control.
Education and Expertise
Michael Millar holds a Master of Science (MS) degree in Molecular Biology from the University of Maryland Baltimore County. He also earned a Bachelor of Science (BS) degree in Biology from Loyola University Maryland. His educational background supports his expertise in molecular biology and manufacturing sciences, which he applies in his current and previous roles in the biotechnology industry.